Sophie Bleuez-Bayle

Saint-etienne-de-valoux, FR 
Saint-etienne-de-valoux, FR 
OverviewLocationsClinical Research

Overview

Sophie Bleuez-Bayle practices in Saint-etienne-de-valoux, France. Her top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Mesothelioma, and Pulmonary Veno-Occlusive Disease.

Her clinical research consists of co-authoring 19 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Saint-etienne-de-valoux, France
Other Locations
Saint Étienne, France
Avenue Albert Raimond, 42055 Saint Étienne Cedex 2, Albert, 42055, France
CHU De St Étienne, Saint-etienne, 42100, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
Enrollment Status: Active_not_recruiting
Publish Date: October 19, 2023
Intervention Type: Other
A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
A Randomized Phase III Clinical Trial to Evaluate the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
Enrollment Status: Completed
Publish Date: August 31, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 1 Less Clinical Trial

19 Total Publications

Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 06, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bleuez-Bayle's expertise for a condition
ConditionClose
        View All 9 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile